pharmaphorum

JANUARY 9, 2023

Novartis’ programme providing free access to its spinal muscular atrophy (SMA) gene therapy Zolgensma is being scaled back to a dozen countries worldwide, according to the company. ” Zolgensma is one of the most expensive therapies available, with a price tag of around $2.1

119

119

pharmaphorum

JANUARY 24, 2022

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Cerner 111

Cerner 111

European Pharmaceutical Review

DECEMBER 27, 2023

This round-trip shipping was especially challenging during the early days of the COVID-19 pandemic, which coincided with initial attempts to establish CAR T-cell therapies in daily practice. Due to shipping and manufacturing requirements, the time from a patient being included in the CAR T programme to receiving therapy can be several weeks.

Adverse Reactions 83

Adverse Reactions Immunization Medical Schools Chemotherapy 83